{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T04:08:53Z","timestamp":1789186133195,"version":"build-2803163510"},"reference-count":32,"publisher":"Japanese Circulation Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ Rep"],"published-print":{"date-parts":[[2026,9,10]]},"DOI":"10.1253\/circrep.cr-26-0144","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:09:57Z","timestamp":1783030197000},"page":"1490-1499","source":"Crossref","is-referenced-by-count":0,"title":["Profiles and Prognostic Value of a Non-Invasive Liver Fibrosis Marker in Patients With Acute and Chronic Coronary Syndrome\u3000\u2015 Insights From the CLIDAS-PCI \u2015"],"prefix":"10.1253","volume":"8","author":[{"given":"Wataru","family":"Saitoh","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka Metropolitan University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takenobu","family":"Shimada","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka Metropolitan University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiju","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka Metropolitan University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Shibata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka Metropolitan University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asahiro","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka Metropolitan University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Otsuka","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka Metropolitan University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Okamura","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Medical Informatics, Osaka Metropolitan University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Matoba","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahide","family":"Kohro","sequence":"additional","affiliation":[{"name":"Department of Clinical Informatics, Jichi Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Oba","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisaki","family":"Makimoto","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Kabutoya","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Imai","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Pharmacology, Jichi Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuomi","family":"Kario","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arihiro","family":"Kiyosue","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kodera","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Mizuno","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital"},{"name":"Development Bank of Japan Inc."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Nochioka","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaharu","family":"Nakayama","sequence":"additional","affiliation":[{"name":"Department of Medical Informatics, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamasa","family":"Iwai","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Miyamoto","sequence":"additional","affiliation":[{"name":"Open Innovation Center, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanobu","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"},{"name":"Department of Medical Information Science, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taishi","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Medical Information Science, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Tsujita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisahiko","family":"Sato","sequence":"additional","affiliation":[{"name":"Precision Inc."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Akashi","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Jichi Medical University Saitama Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Fujita","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Jichi Medical University Saitama Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryozo","family":"Nagai","sequence":"additional","affiliation":[{"name":"Jichi Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the CLIDAS Research Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Byrne CD, Targher G. NAFLD: A multisystem disease. <i>J Hepatol<\/i> 2015; 62: S47\u2013S64.","DOI":"10.1016\/j.jhep.2014.12.012"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Lonardo A, Nascimbeni F, Mantovani A, Targher G. Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence? <i>J Hepatol<\/i> 2018; 68: 335\u2013352.","DOI":"10.1016\/j.jhep.2017.09.021"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Tanaka A. Cardiovascular, kidney, and metabolic network medicine: Past, present, and future challenges and directions. <i>Circ J<\/i> 2026; 90: 449\u2013457, doi:10.1253\/circj.CJ-26-0129.","DOI":"10.1253\/circj.CJ-26-0129"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Zheng H, Sechi LA, Navarese EP, Casu G, Vidili G. Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: A comprehensive review. <i>Cardiovasc Diabetol<\/i> 2024; 23: 346, doi:10.1186\/s12933-024-02434-5.","DOI":"10.1186\/s12933-024-02434-5"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Ogawa T, Sato T, Tanaka M, Akiyama Y, Nakata K, Kouzu H, et al. Metabolic dysfunction-associated steatotic liver disease (MASLD) is an independent risk factor for the development of ischemic heart disease: A 10-year cohort study. <i>Circ Rep<\/i> 2025; 7: 350\u2013358, doi:10.1253\/circrep.cr-25-0019.","DOI":"10.1253\/circrep.CR-25-0019"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Chen Y, Xu M, Wang T, Sun J, Sun W, Xu B, et al. Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease. <i>Atherosclerosis<\/i> 2015; 241: 145\u2013150, doi:10.1016\/j.atherosclerosis.2015.05.002.","DOI":"10.1016\/j.atherosclerosis.2015.05.002"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. <i>Hepatology<\/i> 2006; 43: 1317\u20131325, doi:10.1002\/hep.21178.","DOI":"10.1002\/hep.21178"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Chen Q, Li Q, Li D, Chen X, Liu Z, Hu G, et al. Association between liver fibrosis scores and the risk of mortality among patients with coronary artery disease. <i>Atherosclerosis<\/i> 2020; 299: 45\u201352, doi:10.1016\/j.atherosclerosis.2020.03.010.","DOI":"10.1016\/j.atherosclerosis.2020.03.010"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Jin JL, Zhang HW, Cao YX, Liu HH, Hua Q, Li YF, et al. Liver fibrosis scores and coronary atherosclerosis: Novel findings in patients with stable coronary artery disease. <i>Hepatol Int<\/i> 2021; 15: 413\u2013423, doi:10.1007\/s12072-021-10167-w.","DOI":"10.1007\/s12072-021-10167-w"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Lin J, Huang Y, Xu B, Gu X, Huang J, Sun J, et al. Effect of dapagliflozin on metabolic dysfunction-associated steatohepatitis: Multicentre, double blind, randomised, placebo controlled trial. <i>BMJ<\/i> 2025; 389: e083735, doi:10.1136\/bmj-2024-083735.","DOI":"10.1136\/bmj-2024-083735"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Sanyal AJ, Newsome PN, Kliers I, \u00d8stergaard LH, Long MT, Kj\u00e6r MS, et al. Phase 3 trial of semaglutide in metabolic dysfunction-associated steatohepatitis. <i>N Engl J Med<\/i> 2025; 392: 2089\u20132099, doi:10.1056\/nejmoa2413258.","DOI":"10.1056\/NEJMoa2413258"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Lopaschuk GD, Verma S. Mechanisms of cardiovascular benefits of sodium glucose co-transporter 2 (SGLT2) inhibitors: A state-of-the-art review. <i>JACC Basic Transl Sci<\/i> 2020; 5: 632\u2013644, doi:10.1016\/j.jacbts.2020.02.004.","DOI":"10.1016\/j.jacbts.2020.02.004"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Heffron SP, Parham JS, Pendse J, Alem\u00e1n JO. Treatment of obesity in mitigating metabolic risk. <i>Circ Res<\/i> 2020; 126: 1646\u20131665, doi:10.1161\/CIRCRESAHA.119.315897.","DOI":"10.1161\/CIRCRESAHA.119.315897"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Oba Y, Kabutoya T, Kohro T, Imai Y, Kario K, Sato H, et al. Relationships among heart rate, \u03b2-blocker dosage, and prognosis in patients with coronary artery disease in a real-world database using a multimodal data acquisition system. <i>Circ J<\/i> 2023; 87: 336\u2013344, doi:10.1253\/circj.CJ-22-0314.","DOI":"10.1253\/circj.CJ-22-0314"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Akashi N, Matoba T, Kohro T, Oba Y, Kabutoya T, Imai Y, et al. Sex differences in long-term outcomes in patients with chronic coronary syndrome after percutaneous coronary intervention: Insights from a Japanese real-world database using a storage system. <i>Circ J<\/i> 2023; 87: 775\u2013782, doi:10.1253\/circj.CJ-22-0653.","DOI":"10.1253\/circj.CJ-22-0653"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Matoba T, Katsuki S, Nakano Y, Kawahara T, Kimura M, Hino R, et al. Efficacy and safety of high-intensity statins in Japanese patients after percutaneous coronary intervention: Insights from the Clinical Deep Data Accumulation System (CLIDAS\u00ae). <i>Circ J<\/i> 2025; 89: 1204\u20131215, doi:10.1253\/circj.CJ-25-0066.","DOI":"10.1253\/circj.CJ-25-0066"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Matoba T, Kohro T, Fujita H, Nakayama M, Kiyosue A, Miyamoto Y, et al. Architecture of the Japan ischemic heart disease multimodal prospective data acquisition for precision treatment (J-IMPACT) system. <i>Int Heart J<\/i> 2019; 60: 264\u2013270, doi:10.1536\/ihj.18-113.","DOI":"10.1536\/ihj.18-113"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Nakayama M, Takehana K, Kohro T, Matoba T, Tsutsui H, Nagai R. Standard export data format for extension storage of standardized structured medical information exchange. <i>Circ Rep<\/i> 2020; 2: 587\u2013616, doi:10.1253\/circrep.CR-20-0077.","DOI":"10.1253\/circrep.CR-20-0077"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Shah AG, Lydecker A, Murray K, Tetri BN, Contos MJ, Sanyal AJ, et al. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. <i>Clin Gastroenterol Hepatol<\/i> 2009; 7: 1104\u20131112, doi:10.1016\/j.cgh.2009.05.033.","DOI":"10.1016\/j.cgh.2009.05.033"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. <i>Am J Kidney Dis<\/i> 2009; 53: 982\u2013992, doi:10.1053\/j.ajkd.2008.12.034.","DOI":"10.1053\/j.ajkd.2008.12.034"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Stevens PE, Levin A; Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: Synopsis of the kidney disease: Improving global outcomes 2012 clinical practice guideline. <i>Ann Intern Med<\/i> 2013; 158: 825\u2013830, doi:10.7326\/0003-4819-158-11-201306040-00007.","DOI":"10.7326\/0003-4819-158-11-201306040-00007"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, Abdelmalek MF, Caldwell S, Barb D, et al. AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. <i>Hepatology<\/i> 2023; 77: 1797\u20131835, doi:10.1097\/HEP.0000000000000323.","DOI":"10.1097\/HEP.0000000000000323"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Kern A, Stomp\u00f3r T, Bojko K, Sienkiewicz E, Pawlak S, Pawlak K, et al. Comparative ten-year outcomes in chronic and acute coronary syndrome patients undergoing invasive diagnostics: Insights from the KORONEF Registry. <i>Biomedicines<\/i> 2024; 12: 2672, doi:10.3390\/biomedicines12122672.","DOI":"10.3390\/biomedicines12122672"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Husain K. Inflammation, oxidative stress and renin angiotensin system in atherosclerosis. <i>World J Biol Chem<\/i> 2015; 6: 209, doi:10.4331\/wjbc.v6.i3.209.","DOI":"10.4331\/wjbc.v6.i3.209"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Hara T, Sata M. Association between chronic inflammation and cardiovascular disease: Focus on high-sensitivity C-reactive protein. <i>Circ J<\/i> 2026, doi:10.1253\/circj.CJ-26-0173.","DOI":"10.1253\/circj.CJ-26-0173"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26. Evans WJ, Morley JE, Argil\u00e9s J, Bales C, Baracos V, Guttridge D, et al. Cachexia: A new definition. <i>Clin Nutr<\/i> 2008; 27: 793\u2013799, doi:10.1016\/j.clnu.2008.06.013.","DOI":"10.1016\/j.clnu.2008.06.013"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Morley JE, Vellas B, Abellan van Kan G, Anker SD, Bauer JM, Bernabei R, et al. Frailty consensus: A call to action. <i>J Am Med Dir Assoc<\/i> 2013; 14: 392\u2013397, doi:10.1016\/j.jamda.2013.03.022.","DOI":"10.1016\/j.jamda.2013.03.022"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28. Alfaro-Alvarado FA, Rosas-Barrientos JV, Ocharan-Hern\u00e1ndez ME, D\u00edaz-Chiguer D, Vargas-De-Le\u00f3n C. Association between sarcopenia and poor glycemic control in older adults with type 2 diabetes mellitus. <i>Diseases<\/i> 2023; 11: 175, doi:10.3390\/diseases11040175.","DOI":"10.3390\/diseases11040175"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Carnethon MR, John P, De Chavez D, Biggs ML, Lewis CE, Pankow JS, et al. Association of weight status with mortality in adults with incident diabetes. <i>J Am Med Assoc<\/i> 2012; 308: 581\u2013590.","DOI":"10.1001\/jama.2012.9282"},{"key":"30","doi-asserted-by":"publisher","unstructured":"30. Yoshikawa M, Honda A, Arashi H, Shibahashi E, Otsuki H, Kawada-Watanabe E, et al. Addition of ezetimibe to intensive lipid-lowering therapy is associated with a lower incidence of heart failure in patients with acute coronary syndrome. <i>Circ J<\/i> 2024; 88: 1819\u20131824, doi:10.1253\/circj.CJ-24-0536.","DOI":"10.1253\/circj.CJ-24-0536"},{"key":"31","doi-asserted-by":"publisher","unstructured":"31. Seiyama K, Oka A, Miyoshi T, Sudo Y, Takagi W, Ugawa S, et al. Impact of an intensive lipid-lowering therapy protocol on achieving target low-density lipoprotein cholesterol levels in patients with acute coronary syndrome. <i>Circ Rep<\/i> 2025; 7: 131\u2013138, doi:10.1253\/circrep.CR-24-0071.","DOI":"10.1253\/circrep.CR-24-0071"},{"key":"32","doi-asserted-by":"publisher","unstructured":"32. Kanda D, Tokushige A, Kajiya T, Arima T, Kataoka T, Arikawa R, et al. Characteristics of patients with acute coronary syndrome and lipid management status insights from the Optimal Therapy for All Kagoshima Acute Coronary Syndrome (OK-ACS) Registry. <i>Circ J<\/i> 2025; 89: 1266\u20131277, doi:10.1253\/circj.CJ-25-0083.","DOI":"10.1253\/circj.CJ-25-0083"}],"container-title":["Circulation Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/8\/9\/8_CR-26-0144\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:25:17Z","timestamp":1789183517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/8\/9\/8_CR-26-0144\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1253\/circrep.cr-26-0144","relation":{},"ISSN":["2434-0790"],"issn-type":[{"value":"2434-0790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"article-number":"CR-26-0144"}}